Who is sponsoring NCT00432263?

NCT00432263 is sponsored by Pfizer.

What condition does NCT00432263 study?

NCT00432263 studies Brain Injuries.

What drugs are being tested in NCT00432263?

Interventions: Genotropin (PN-180,307) Somatropin.

What is the status of NCT00432263?

NCT00432263 is currently WITHDRAWN.

Last reviewed 2015-04-21 · How we verify

Placebo-Controlled Trial On The Efficacy Of Growth Hormone Replacement Therapy In Patients With Growth Hormone Deficiency After Traumatic Brain Injury

NCT00432263 Phase 4 WITHDRAWN

To establish the effects of genotropin replacement in patients with severe growth hormone deficiency after traumatic brain injury on cognitive function.

Details

Lead sponsor	Pfizer
Phase	Phase 4
Status	WITHDRAWN
Start date	2007-04

Conditions

Brain Injuries

Interventions

Genotropin (PN-180,307) Somatropin

Primary outcomes

The primary endpoint is the change from baseline in the CogState™ composite score at Week 36.